Cart
sales@molnova.com
Totrombopag
CAS No. 376592-42-6
Totrombopag( —— )
Catalog No. M34722 CAS No. 376592-42-6
Totrombopag (SB559448) is a candidate compound for action on RSV polymerase.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 787 | In Stock |
|
| 10MG | 1074 | In Stock |
|
| 25MG | 1511 | In Stock |
|
| 50MG | 1841 | In Stock |
|
| 100MG | 2325 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | 4557 | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameTotrombopag
-
NoteResearch use only, not for human use.
-
Brief DescriptionTotrombopag (SB559448) is a candidate compound for action on RSV polymerase.
-
DescriptionTotrombopag (SB559448) is a candidate compound for action on RSV polymerase.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayJAK/STAT Signaling
-
TargetSTAT
-
RecptorRSV
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number376592-42-6
-
Formula Weight466.49
-
Molecular FormulaC25H22N8O2
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESO=C1N(N=C(C)C1N=NC2=C(O)C(=CC=C2)C3=CC(=CC=C3)C=4NN=NN4)C5=CC(C)=C(C)C=C5
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
BTA-9881
BTA-9881 is a novel RSV fusion inhibitor with oral activity and antiviral activity for the study of respiratory syncytial virus infections.
-
AS2863619
AS2863619 is an orally active?inhibitor of cyclin-dependent kinase 8 (CDK8) and CDK19 (IC50s of 0.61 nM and 4.28 nM, respectively).
-
Stafia-1
Stafia-1 is a potent STAT5a inhibitor ( IC50=22.2 μM). Stafia-1 displays high selectivity over STAT5b and other STAT family members.
